References
- Marmor MF, Hu J. Effect of disease stage on progression of hydroxychloroquine retinopathy. JAMA Ophthalmol. 2014;132:1105–12. doi:10.1001/jamaophthalmol.2014.1099.
- Kellner S, Weinitz S, Farmand G, Kellner U. Cystoid macular edema and epiretinal membrane formation during progression of chloroquine retinopathy after drug cessation. Br J Ophthalmol. 2014;98:200–06. doi:10.1136/bjophthalmol-2013-304546.
- Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF; American Academy Ophthalmology. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology. 2011;118:415–22. doi:10.1016/j.ophtha.2010.11.017.
- Marmor MF, Kellner U, Lai TY, Melles RB, Wf M; American Academy Ophthalmology. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 Revision). Ophthalmology. 2016;123:1386–94. doi:10.1016/j.ophtha.2016.01.058.
- Hussain N, Hussain A. Diametric measurement of foveal avascular zone in healthy young adults using optical coherence tomography angiography. Int J Retina Vitreous. 2016;2:27. eCollection 2016. doi:10.1186/s40942-016-0053-8.
- Wylegala A, Teper S, Dobrowolski D, Wylegala E. Optical coherence angiography: a review. Medicine (Baltimore). 2016;95:4907. doi:10.1097/MD.0000000000004864.
- Marmor MF. Comparison of screening procedures in hydroxychloroquine toxicity. Arch Ophthalmol. 2012;130:461–69. doi:10.1001/archophthalmol.2011.371.
- Kellner S, Weinitz S, Kellner U. Spectral domain optical coherence tomography detects early stages of chloroquine retinopathy similar to multifocal electroretinography, fundus autofluorescence and near-infrared autofluorescence. Br J Ophthalmol. 2009;93:1444–47. doi:10.1136/bjo.2008.153007.
- Mititelu M, Wong BJ, Brenner M, Bryar PJ, Jampol LM, Fawzi AA. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging. JAMA Ophthalmol. 2013;131:1187–97. doi:10.1001/jamaophthalmol.2013.4244.
- Mo S, Krawitz B, Efstathiadis E, Geyman L, Weitz R, Chui TY, Carrol J, Dubra A, Rosen RB. Imaging foveal microvasculature: optical coherence tomography angiography versus adaptive optics scanning light ophthalmoscope fluorescein angiography. Invest Ophthalmol Vis Sci. 2016;57:130–40. doi:10.1167/iovs.15-18932.
- Melles RB, Marmor MF. Pericentral retinopathy and racial differences in hydroxychloroquine toxicity. Ophthalmology. 2015;122:110–16. doi:10.1016/j.ophtha.2014.07.018.
- Lee DH, Melles RB, Joe SG, Lee JY, Kim JG, Lee CK, Yoo B, Koo BS, Kim JT, Marmor MF, et al. Pericentral hydroxychloroquine retinopathy in Korean patients. Ophthalmology. 2015;122:1252–56. doi:10.1016/j.ophtha.2015.01.014.
- Rodriguez-Padilla JA, Hedges TR, 3rd, Monson B, Srinivasan V, Wojtkowski M, Reichel E, Duker JS, Schuman JS, Fujimato JG. High-speed ultra-high resolution optical coherence tomography findings in hydroxychloroquine retinopathy. Arch Ophthalmol. 2007;125:775–80. doi:10.1001/archopht.125.6.775.
- Lee MG, Kim SJ, Ham DI, Kang SW, Kee C, Lee J, Cha HS, Koh EM. Macular retinal ganglion cell inner plexiform layer thickness in patients on hydroxychloroquine therapy. Invest Ophthalmol Vis Sci. 2014;56:396–402. doi:10.1167/iovs.14-15138.
- de Sisternes L, Hu J, Rubin DL, Marmor MF. Localization of damage in progressive hydroxychloroquine retinopathy on and off the drug: inner versus outer retina, parafovea versus peripheral fovea. Invest Ophthalmol Vis Sci. 2015;56:3415–26. doi:10.1167/iovs.14-16345.
- La Spina C, Carnevali A, Marchese A, Querques G, Bandello F. Reproducibility and reliability of optical coherence tomography angiography for foveal avascular zone evaluation and measurement in different settings. Retina. 2017;37:1636–41. doi:10.1097/IAE.0000000000001426.
- Yanik Odabas O, Demirel S, Ozmert E, Batioglu F. Repeatability of automated vessel density and superficial and deep foveal avascular zone area measurements using optical coherence tomography angiography: diurnal findings. Retina. 2018;38:1238–45. doi:10.1097/IAE.0000000000001671.